Fig. 1

IIM patients have a lower CD3 + cell population and a higher CD14 + cell population in the pheripheral blood. A Flow cytometry analyses of CD3, CD14, CD19, and CD56 surface markers in peripheral blood mononuclear cells (PBMCs) of IIM patients with anti-aminoacyl-tRNA synthetase (ARS + , n = 40), or with anti-MDA5 antibody (MDA5 + , n = 24), and healthy controls (HC, n = 60). B Absolute cell numbers of CD3 + , CD14 + , CD19 + , and CD56 + cells of IIM patients with anti-aminoacyl-tRNA synthetase (ARS + , n = 25), or with anti-MDA5 antibody (MDA5 + , n = 18). Each dot was displayed for each data from the enrolled subjects. Data are presented as means ± SD. The p values were calculated using Kruskal–Wallis test between the ARS + , MDA5 + , and HC groups. ns, not significant